Med-Net Compliance

OCTOBER 27, 2022

According to court documents and evidence presented at trial, the psychologist caused the submission of fraudulent Medicare claims from July 2016 through June 2019 for psychotherapy services purportedly provided to nursing home residents in Chicago and surrounding areas.

Nursing Homes 59

Nursing Homes Fraud US Department of Health and Human Services Nurses 59

Healthcare Compliance Blog

FEBRUARY 2, 2022

A New York optician has pled guilty to grand larceny for submitting false claims for optician services that he alleged were for specific nursing home residents, but which were never provided. Additionally, it is necessary that the billing office ensures that no double billing occurs by the nursing home and any consultant.

Nursing Homes 59

Nursing Homes Fraud Medicaid Medicaid 59

Healthcare Compliance Blog

FEBRUARY 8, 2022

The United States has filed a lawsuit against an Alabama psychiatrist for improper prescribing of Nuedexta to nursing home residents. In return, the psychiatrist prescribed Nuedexta to nursing home residents who did not have pseudobulbar affect.

Nursing Homes 52

Nursing Homes Nurses Compliance Medicare 52

AIHC

FEBRUARY 16, 2024

Lessons Learned about Consequences & Incentives Submitted by the AIHC Education Department Introduction The Office of Inspector General has released the new General Compliance Program Guidance or “GCPG” in late 2023. The article states “An example of this was Wells Fargo in 2016.

Compliance 52

Compliance US Department of Health and Human Services COVID-19 Hospitals 52

AIHC

FEBRUARY 16, 2024

Lessons Learned about Consequences & Incentives Submitted by the AIHC Education Department Introduction The Office of Inspector General has released the new General Compliance Program Guidance or “GCPG” in late 2023. The article states “An example of this was Wells Fargo in 2016.

Compliance 52

Compliance US Department of Health and Human Services COVID-19 Hospitals 52

Drug & Device Law

DECEMBER 29, 2023

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Negligence requires an evaluation of a defendant’s reasonableness, and all relevant NC authority includes relevant regulatory compliance in that mix. Plaintiffs’ own litigation strategy thus opened the door to compliance evidence. Monsanto Co. , denied , 144 S.

FDA 105

FDA US Department of Health and Human Services COVID-19 Informed Consent 105